Children treated for epileptic encephalopathies show improved glucose metabolism

Pediatrics International

Volumn 52, Issue 6, 2010, Pages 883-887

  Zhai, Qiongxiang ^a   Gui, Juan ^a   Zhang, Yuxin ^a   Qiao, Huixian ^a  

^a GUANGDONG PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

18FDG PET; cerebral glucose metabolism; childhood epileptic encephalopathy; epileptic; positron emission tomography

Indexed keywords

CORTICOTROPIN; FLUORODEOXYGLUCOSE F 18; LAMOTRIGINE; NITRAZEPAM; TOPIRAMATE; VALPROIC ACID;

ARTICLE; CHILD; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; HUMAN; INFANTILE SPASM; LENNOX GASTAUT SYNDROME; MALE; POSITRON EMISSION TOMOGRAPHY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

ANTICONVULSANTS; BLOOD GLUCOSE; BRAIN; CHILD; CHILD, PRESCHOOL; DOMINANCE, CEREBRAL; DRUG THERAPY, COMBINATION; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; INFANT; MALE; MENTAL RETARDATION; POSITRON-EMISSION TOMOGRAPHY; SPASMS, INFANTILE;

EID: 78650502289     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03232.x     Document Type: Article

References (34)

1. Seth A, Aneja S, Taluja V,. Epileptic encephalopathies of early childhood. Indian. Pediatr. 2001; 38: 390-6.
2. Wirrell E, Farrell K, Whiting S,. The epileptic encephalopathies of infancy and childhood. Can. J. Neurol. Sci. 2005; 32: 409-18.
3. Guerrini R, Aicardi J,. Epileptic encephalopathies with myoclonic seizures in infants and children (severe myoclonic epilepsy and myoclonic-astatic epilepsy). J. Clin. Neurophysiol. 2003; 20: 449-61.
4. Shields WD,. Catastrophic epilepsy in childhood. Epilepsia 2000; 41 (Suppl. 2): S2-6.
5. You SJ, Lee JK, Ko TS,. Epilepsy surgery in a patient with Lennox-Gastaut syndrome and cortical dysplasia. Brain. Dev. 2007; 29: 167-70.
6. Markand ON,. Lennox-Gastaut syndrome (childhood epileptic encephalopathy). J. Clin. Neurophysiol. 2003; 20: 426-41.
7. Metsahonkala L, Gaily E, Rantala H, et al. Focal and global cortical hypometabolism in patients with newly diagnosed infantile spasms. Neurology 2002; 58: 1646-51.
8. Trasmonte JV, Barron TF,. Infantile spasms: A proposal for a staged evaluation. Pediatr. Neurol. 1998; 19: 368-71.
9. Nabbout R, Dulac O,. Epileptic encephalopathies: A brief overview. J. Clin. Neurophysiol. 2003; 20: 393-7.
10. Nabbout R, Dulac O,. Epileptic syndromes in infancy and childhood. Curr. Opin. Neurol. 2008; 21: 161-6.
11. la Fougère C, Rominger A, Förster S, Geisler J, Bartenstein P,. PET and SPECT in epilepsy: A critical review. Epilepsy Behav. 2009; 15: 50-5.
12. Macapinlac HA,. Clinical applications of positron emission tomography/ computed tomography treatment planning. Semin. Nucl. Med. 2008; 38: 137-40.
13. 18F]FDG-PET in nonrefractory partial epilepsy. Epilepsia 2005; 14: 1654-60.
14. Thorngren-Jerneck K, Hellstrom-Westas L, Ryding E, Rosen I,. Cerebral glucose metabolism and early EEG/aEEG in term newborn infants with hypoxic-ischemic encephalopathy. Pediatr. Res. 2003; 54: 854-60.
15. 18FDG-PET. Neurology 2007; 68: 655-9.
16. Henry TR, Votaw JR,. The role of positron emission tomography with [18F]fluorodeoxyglucose in the evaluation of the epilepsies. Neuroimaging Clin. N. Am. 2004; 14: 517-35.
17. Koutroumanidis M, Binnie CD, Panayiotopoulos CP,. Positron emission tomography in partial epilepsies: The clinical point of view. Nucl. Med. Commun., 1998; 19: 1123-6.
18. O'Brien TJ, Hicks RJ, Ware R, Binns DS, Murphy M, Cook MJ,. The utility of a 3-dimensional, large-field-of-view, sodium iodide crystal-based PET scanner in the presurgical evaluation of partial epilepsy. J. Nucl. Med. 2001; 42: 1158-65.
19. Nelissen N, Van Paesschen W, Baete K, et al. Correlations of interictal FDG-PET metabolism and ictal SPECT perfusion changes in human temporal lobe epilepsy with hippocampal sclerosis. NeuroImage 2006; 32: 684-95.
20. Lin TW, Kung de Aburto MA, Dahlbom M, et al. Predicting seizure-free status for temporal lobe epilepsy patients undergoing surgery; prognostic value of quantifying maximal metabolic asymmetry extending over a specified proportion of the temporal lobe. J. Nucl. Med. 2007; 48: 776-82.
21. Schauble B, Cascino GD,. Advances in neuroimaging: Management of partial epileptic syndromes. Neurosurg. Rev. 2003; 26: 233-46.
22. Tai YF, Piccini P,. Application of positron emission tomography (PET) in neurology. J. Neurol. Neurosurg. Psychiatry 2006; 9: 669-76.
23. Ferrie CD, Maisey M, Cox T, et al. Focal abnormalities detected by 18FDG PET in epileptic encephalopathies. Arch. Dis. Child. 1996; 75: 102-7.
24. Ferrie CD, Marsden PK, Maisey MN, Robinson RO,. Cortical and subcortical glucose metabolism in childhood epileptic encephalopathies. J. Neurol. Neurosurg. Psychiatr. 1997; 63: 181-7. doi:10.1136/jnnp.63.2.181.
25. Gur RC, Sussman NM, Alavi A, et al. Positron emission tomography in two cases of childhood epileptic encephalopathy (Lennox-Gastaut syndrome). Neurology 1982; 32: 1191-4.
26. Chugani HT, Mazziotta JC, Engel J, Phelps ME,. The Lennox-Gastaut syndrome: Metabolic subtypes determined by 2-deoxy-2-fluro-D-glucose positron emission tomography. Ann. Neurol. 1987; 21: 4-13.
27. Theodore WH, Rose D, Patronas N, et al. Cerebral glucose metabolism in the Lennox-Gastaut syndrome. Ann. Neurol. 1987; 21: 14-21.
28. Yanai K, Iinuma K, Matsuzawa T, et al. Cerebral glucose utilization in pediatric neurological disorders determined by positron emission tomography. Eur J. Nucl. Med. 1987; 13: 292-6.
29. Miyauchi T, Nomura Y, Ohno S, Kishimoto H, Matsushita M,. Positron emission tomography in three cases of Lennox-Gastaut syndrome. Jpn J. Psychiatry Neurol. 1988; 42: 795-804.
30. Chugani HT, Shields WD, Shewmon DA, Olson DM, Phelps ME, Peacock WJ,. Infantile spasms. I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment. Ann. Neurol. 1990; 27: 406-13.
31. Commission on classification and terminology of the International League against Epilepsy: Proposal for revised classification of epilepsies and epileptic syndromes. Epilepsia 1989; 30: 389-99.
32. Nomori H, Watanabe K, Ohtsuka T, Naruke T, Suemasu K, Uno K,. Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in size. Ann. Thorac. Surg. 2005; 79: 984-8.
33. Ottaviani S, Tinazzi M, Pasquin I, et al. Comparative analysis of visual and semi-quantitative assessment of striatal [123I]FP-CIT-SPET binding in Parkinson's disease. Neurol. Sci. 2006; 27: 397-401.
34. Sadzot B, Debets R, Maquet P, Comar C, Franck G,. PET studies of patients with partial epilepsy: Visual interpretation vs. semi-quantification/ quantification. Acta Neurol. Scand. Suppl. 1994; 152: 175-8.